Feagan, Brian G
Danese, Silvio
Loftus, Edward V Jr
Vermeire, Séverine
Schreiber, Stefan
Ritter, Timothy
Fogel, Ronald
Mehta, Rajiv
Nijhawan, Sandeep
Kempiński, Radosław
Filip, Rafał
Hospodarskyy, Ihor
Seidler, Ursula
Seibold, Frank
Beales, Ian L P
Kim, Hyo Jong
McNally, John
Yun, Chohee
Zhao, Sally
Liu, Xiaopeng
Hsueh, Chia-Hsiang
Tasset, Chantal
Besuyen, Robin
Watanabe, Mamoru
Sandborn, William J
Rogler, Gerhard
Hibi, Toshifumi
Peyrin-Biroulet, Laurent
Funding for this research was provided by:
Gilead Sciences Inc
This article is maintained by: Elsevier
Article Title: Filgotinib as induction and maintenance therapy for ulcerative colitis (SELECTION): a phase 2b/3 double-blind, randomised, placebo-controlled trial
Journal Title: The Lancet
CrossRef DOI link to publisher maintained version: https://doi.org/10.1016/S0140-6736(21)00666-8
CrossRef DOI link to the associated document: https://doi.org/10.1016/S0140-6736(21)00891-6
Content Type: article
Copyright: © 2021 Elsevier Ltd. All rights reserved.